Sinclair Pharma (XPAR:SPH) Liabilities-to-Assets : 0.47 (As of Jun. 2018)

Sinclair Pharma Liabilities-to-Assets Chart

Sinclair Pharma Annual Data
	Trend	Jun07	Jun08	Jun09	Jun10	Jun11	Jun12	Jun13	Jun14	Jun15	Dec17
Liabilities-to-Assets		Get a 7-Day Free Trial					0.30	0.29	0.61	0.63	0.41

Sinclair Pharma Semi-Annual Data
	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Jun17	Dec17	Jun18
Liabilities-to-Assets	Get a 7-Day Free Trial															0.53	0.41	0.44	0.41	0.47

Competitive Comparison of Sinclair Pharma's Liabilities-to-Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Sinclair Pharma's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinclair Pharma's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sinclair Pharma's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Sinclair Pharma's Liabilities-to-Assets falls into.

Sinclair Pharma Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Sinclair Pharma's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2017 is calculated as:

Sinclair Pharma's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinclair Pharma  (XPAR:SPH) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Sinclair Pharma Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinclair Pharma (XPAR:SPH) Business Description